Ganesh Venkataraman Kaundinya, Senior V.P, Research at MOMENTA PHARMACEUTICALS INC (MNTA), sold 821 shares at $15.20 ($12K) on 2017-08-21, disclosed to the SEC on 2017-08-23.
Scheduled sale ($12k) by Senior V.P, Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.20 | 396 | $6K | 48.2% |
| 2 | $15.20 | 425 | $6K | 51.8% |
| Total | $15.20 avg | 821 | $12K | 100% |
| Filing → |
| MNTA | SELL | 2018-08-10 | $18K | — | Filing → |
| MNTA | SELL | 2018-05-23 | $9K | — | Filing → |
| MNTA | SELL | 2018-05-14 | $8K | — | Filing → |